Cargando…
Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy
Therapeutic agents that inhibit a single target often cannot combat a multifactorial disease such as cancer. Thus, multi-target inhibitors (MTIs) are needed to circumvent complications such as the development of resistance. There are two predominant types of MTIs, (a) single drug inhibitor (SDIs) th...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085796/ https://www.ncbi.nlm.nih.gov/pubmed/25013742 http://dx.doi.org/10.4172/2157-7439.1000184 |